Table 2.
Antibiotic resistance profile of S. Enteritidis strain PT1.
| Category | Antibiotics (μg/disk) | Susceptibilitya |
|---|---|---|
| Aminoglycoside | Gentamicin (10 μg) | R |
| Quinolone | Ciprofloxacin (5 μg) | R |
| ESBLs production indicators | Ceftazidime (30 μg) and ceftazidime/clavulanic acid (30/10 μg) | R |
| Cefotaxime (30 μg) and cefotaxime/clavulanic acid (30/10 μg) | R | |
| Aztreonam (30 μg) and Aztreonam/Clavulanic acid (30/10 μg) | R | |
| Fourth generation cephalosporin | Cefepime (30 μg) | R |
| Third-generation cephalosporin | Cefixime (50 μg) | R |
| Carbapenems | Meropenem (10 μg) | S |
| Imipenem (10 μg) | S | |
| Ertapenem (10 μg) | S | |
| Penicillin | Piperacillin and Tazobactam (100/10 μg) | R |
| β-Lactam/β-lactamase inhibitor combinations | Amoxicillin–clavulanic (20/10 μg) | R |
| Polymyxin | Colistin (10 μg) | S |
| Total percent resistance | 9 (69.2%) | |
a
, R: resistant; S: susceptible.